Cellular desensitization is believed to be important for growth control but direct evidence is lacking. In the current study we compared effects of wild-type and down-regulation-resistant mutant m3 muscarinic receptors on Chinese hamster ovary (CHO-K1) cell desensitization, proliferation, and transformation. We found that downregulation of m3 muscarinic acetylcholine receptors was the principal mechanism of desensitization of receptor-activated inositol phosphate phospholipid hydrolysis in these cells. Activation of wild-type and mutant receptors inhibited anchorage-independent growth as assayed by colony formation in agar. However, the potency for inhibition of anchorageindependent growth was greater for cells expressing the mutant receptor. Activation of either receptor also initially inhibited anchorage-dependent cell proliferation in randomly growing populations. Rates of DNA synthesis and cell division were profoundly reduced by carbachol in cells expressing either receptor at early time points. Analysis of cell cycle parameters indicated that cell cycle progression was inhibited at transitions from G1 to S and G2/M to G1 phases. However, mutant receptor effects on anchorage-dependent growth were sustained, whereas wild-type receptor effects were transient. Thus, receptor down-regulation restored cell cycle progression. In contrast, activation of either receptor blocked entry into the cell cycle from quiescence, and this response was not reduced by receptor down-regulation. Therefore, activation of m3 muscarinic acetylcholine receptors inhibited CHO cell anchorage-dependent and -independent growth. In anchored cells carbachol inhibited the cell cycle at three distinct points. Inhibitions at two of these points were eliminated by wild-type receptor down-regulation while the other was not. These results directly demonstrate that desensitization mechanisms can act as principal determinants of cellular growth responses.
proliferation, and transformation. We found that downregulation of m3 muscarinic acetylcholine receptors was the principal mechanism of desensitization of receptor-activated inositol phosphate phospholipid hydrolysis in these cells. Activation of wild-type and mutant receptors inhibited anchorage-independent growth as assayed by colony formation in agar. However, the potency for inhibition of anchorageindependent growth was greater for cells expressing the mutant receptor. Activation of either receptor also initially inhibited anchorage-dependent cell proliferation in randomly growing populations. Rates of DNA synthesis and cell division were profoundly reduced by carbachol in cells expressing either receptor at early time points. Analysis of cell cycle parameters indicated that cell cycle progression was inhibited at transitions from G1 to S and G2/M to G1 phases. However, mutant receptor effects on anchorage-dependent growth were sustained, whereas wild-type receptor effects were transient. Thus, receptor down-regulation restored cell cycle progression. In contrast, activation of either receptor blocked entry into the cell cycle from quiescence, and this response was not reduced by receptor down-regulation. Therefore, activation of m3 muscarinic acetylcholine receptors inhibited CHO cell anchorage-dependent and -independent growth. In anchored cells carbachol inhibited the cell cycle at three distinct points. Inhibitions at two of these points were eliminated by wild-type receptor down-regulation while the other was not. These results directly demonstrate that desensitization mechanisms can act as principal determinants of cellular growth responses.
Whether or not activation of a specific guanine nucleotidebinding protein (G-protein)-linked receptor will influence growth or transformation of a particular cell is unpredictable. Clearly, many G-protein-linked receptors are able to influence the rate of cellular proliferation (1, 2) . However, a specific receptor may influence growth in one cell type but not in another. Furthermore, two receptors that activate similar intracellular second messenger pathways may or may not influence growth in the same cell. In vitro studies have also shown that G-protein-linked receptors can act as agonistdependent oncogenes in some cell models (3) (4) (5) (6) ). Yet, transforming effects of these receptors must be rare as they function physiologically in normal tissues. One parameter that varies depending upon the specific cell and the specific receptor and that may help explain these disparate observations is desensitization.
Desensitization is the process whereby continuous or repeated exposure to a stimulus results in a waning of the cellular response. Physiologically desensitization is manifest in the processes of tachyphylaxis and adaptation and is of major consequence in pharmacologic therapy. Cellular desensitization occurs at the level of the receptor and the level of intracellular effectors. Receptor desensitization has been widely studied and involves several processes, including uncoupling, sequestration, and down-regulation (7, 8) . Receptor down-regulation is the agonist-induced loss of receptors from the cell. In addition to down-regulation of receptors, prolonged agonist treatment also leads to down-regulation of G proteins (9) (10) (11) (12) (13) and intracellular effectors such as protein kinase C (14) and the inositol 1,4,5-trisphosphate receptor (15 (16, 17) , all desensitization mechanisms could be involved in determining the ultimate biological response. Previously it has been suggested that receptor down-regulation or desensitization accounted for alterations in cell growth responses (18, 19) ; however, direct evidence supporting this hypothesis was lacking. In this study we directly examined the importance of receptor down-regulation on the growth inhibitory effects of m3 muscarinic acetylcholine (m3 ACh) receptor activation on Chinese hamster ovary (CHO-K1) cells. m3 ACh receptors belong to the family of seven transmembrane-spanning Gprotein-linked receptors. Activation of m3 ACh receptors has been reported to lead to stimulation of cell growth (6, 20) and transformation (5, 6) or to inhibition of growth (21, 22) and reversal of transformation (23) in different cell models. The mechanisms responsible for these differences in growth actions are not currently understood. However, in all cases, development of the full cellular growth effect requires a prolonged duration of agonist exposure. Therefore, desensitization mechanisms might be expected to *To whom reprint requests should be addressed.
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human m3 ACh receptor with three carboxyl-terminal threonines converted to alanines (Hm3ala). In previous studies we found that this mutant receptor bound ligand and coupled to intracellular effectors equivalently to the wild-type human m3 ACh receptor (Hm3) (24) . However, the mutant receptors were severely impaired in their ability to down-regulate. In the current study we (24) . Atropine completely blocked the inhibitory effects of CCH (data not shown). CCH had no effect on DNA synthesis in serum-starved cells, indicating that the inhibition required the presence of a growth stimulus (data not shown). These observations agree with those previously reported for growth-inhibitory effects after activation of ml ACh receptors in A9 L cells (21) and m3 ACh receptors on small lung cell carcinomas (22) . While there were no differences in the growth-inhibitory effects of either receptor in the short term, there was a significant difference in their effects over the longer time period (2 weeks) of an assay of colony formation in soft agar (Fig. 2B) formation in a concentration-dependent manner. However, the effect of activation of the mutant receptor was more pronounced and occurred at a lower concentration of agonist. The ability to inhibit anchorage-independent growth has been previously reported for the m3 ACh receptor (23, 26) . CCH did not affect colony formation in native CHO cells, which do not express endogenous ACh receptors (data not shown).
Since significant down-regulation of m3 ACh receptors required several hours (24), we examined the effect of agonist treatment on cell numbers for up to 4 days. Cells expressing wild-type receptors were growth inhibited over the first 24 hr of treatment but returned to control rates of growth at later times (Fig. 3A) . In contrast, cells expressing the downregulation-resistant receptors were severely growth inhibited at all times to at least 4 days of culture (Fig. 3B) . The effects of activation of the mutant receptor were reversible upon removal of the agonist (data not shown). A similar pattern of inhibition was observed when incorporation of [3H]thymidine into DNA was followed over several days of culturing (Fig. 4) . To further define the inhibitory actions of m3 ACh receptor activation, effects on early events in the cell cycle were examined. Asynchronously dividing cells treated with CCH for various times showed a rapid inhibition of DNA synthesis (Fig.  6A ). This observation indicated that the previously noted inhibition of G1 to S transition occurred in late G1 or early S phase. In a different assay, utilizing serum-starved quiescent cells, CCH treatment prevented serum-stimulated reentry of cells into the cell cycle (Fig. 6B) . Unlike in randomly cycling, in quiescent cells, activation of either wild-type or mutant receptors caused a persistent inhibitory effect. Receptor downregulation was identical in serum-fed and serum-starved cells (data not shown). Thus, a clear difference in sensitivity to receptor down-regulation was observed between inhibition of G1 to S and Go to S transition.
The cellular basis of the difference between the impact of m3 ACh receptor down-regulation on inhibition of cell entry into and progression through the cell cycle is unclear. One possible explanation would involve the existence of a temporally sensitive step in serum-induced progression toward S phase. An alternative explanation would involve differences in sensitivity to m3 ACh receptor activation. To discriminate between these two models, cells were pretreated with CCH during the serum deprivation period to induce receptor down-regulation before serum stimulation. When this protocol was utilized, CCH pretreatment sufficient for maximal receptor down-regulation did not prevent the inhibitory effects of CCH on serumstimulated DNA synthesis (Fig. 7) . This was not due to a nonreversible effect as CCH pretreatment itself had only a small effect on serum-induced increases in DNA synthesis. Thus, the m3 ACh receptor-activated mechanisms that prevented cells from entering the cell cycle most likely were more sensitive than those involved in the inhibition of cycling cells. These observations indicate that in quiescent cells, activation of m3 ACh receptors blocks Go to S transition, and this inhibition is not relieved by receptor desensitization. In contrast, in cycling CHO cells, activation of m3 ACh receptors inhibits transition from G1 to S and from G2/M to G, phases, and receptor desensitization relieves these inhibitory effects. Further investigations will be necessary to determine the cell cycle-specific mechanisms involved in these growth-inhibitory effects.
DISCUSSION
In the current study, activation of m3 ACh receptors led to a profound inhibition of CHO cell growth and transformation. However, in normally growing populations of CHO cells, activation of wild-type Hm3 receptors had only a transient effect on growth, whereas Hm3ala, a mutant receptor deficient in the ability to down-regulate and desensitize, had a persistent effect. These data clearly demonstrate that alteration of the extent of receptor desensitization has a profound influence on cellular growth regulation by G-protein-linked receptors. Thus, characteristics of receptor desensitization are likely as important as the duration of stimulant exposure in determining the ultimate cellular response. The balance between the rate of signal attenuation due to desensitization and the magnitude and duration of signal required for a growth effect determines whether the effect is observed.
Desensitization characteristics depend upon the receptor, the biological response being investigated, and the cell model. The current data indicate that, of the many processes that are potentially involved in cellular desensitization, Hm3 receptor down-regulation was the principal mechanism responsible for desensitization of PPI hydrolysis and cell growth inhibition in CHO cells. In contrast, we have found that in HEK293 cells, rapid desensitization of Hm3 receptors occurs in the absence of receptor down-regulation (27 Activation of wild-type and mutant receptors also led to an inhibition of anchorage-independent cell growth. This effect has been referred to as "reverse transformation" and has previously been reported as a consequence of activation of ml or m3 ACh receptors in CHO cells (23, 26) . It was suggested that Ca2+ entry accounted for the reverse transforming effects of m3 ACh receptor activation (23) . In the current study anchorage-independent growth was inhibited by wild-type and desensitization-resistant receptors. A difference in concentration dependence between the effects mediated by these two receptors likely represented the influence of wild-type receptor desensitization. Currently it is unclear whether inhibition of colony formation requires sustained receptor function or whether inhibition during a critical early period results in a prolonged effect. Thus, it is difficult to determine whether this effect on cellular transformation represents a separate inhibitory mechanism or is the consequence of the inhibitory effects noted on the cell cycle.
In the current model, receptor desensitization relieved an initial growth effect. In other cases, receptor desensitization may prevent the occurrence of a growth response. Physiologically, many receptors may desensitize too rapidly for growth effects to be manifest, which may explain the lack of cell growth response often observed after activation of G-proteincoupled receptors. In this way desensitization may serve as a protective mechanism that prevents undesirable growth effects. Thus, receptor desensitization is likely to be an essential component of normal cell growth control. In the current study, desensitization limited an inhibitory effect of receptor activation on proliferation and transformation. Since growth effects generally require prolonged signals, by analogy, in different cell models desensitization would also be expected to limit other growth effects including mitogenesis (6, 20) and transformation (3-6). Thus, mutations that result in the loss of normal receptor desensitization, similar to mutations that constitutively activate receptors (4), may lead toward cellular transformation. In view of the important role of receptor desensitization as a limit of growth-inhibitory effects shown in the current study, the relevance of receptor desensitization in cellular transformation clearly needs to be examined.
